CytoDyn, Inc. (CYDY)
0.20
0.00 (0.00%)
USD |
OTCM |
Oct 14, 16:00
CytoDyn Market Cap : 274.70M for Oct. 14, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 14, 2026 | 274.70M |
| October 13, 2026 | 273.17M |
| October 12, 2026 | 274.70M |
| October 09, 2026 | 274.70M |
| October 08, 2026 | 276.76M |
| October 07, 2026 | 274.57M |
| October 06, 2026 | 274.70M |
| October 05, 2026 | 274.70M |
| October 02, 2026 | 274.70M |
| October 01, 2026 | 273.33M |
| September 30, 2026 | 281.57M |
| September 29, 2026 | 277.45M |
| September 28, 2026 | 297.39M |
| September 25, 2026 | 311.79M |
| September 24, 2026 | 292.61M |
| September 23, 2026 | 285.69M |
| September 22, 2026 | 282.26M |
| September 21, 2026 | 298.81M |
| September 18, 2026 | 293.55M |
| September 17, 2026 | 288.44M |
| September 16, 2026 | 280.20M |
| September 15, 2026 | 275.66M |
| September 14, 2026 | 271.68M |
| September 11, 2026 | 271.34M |
| September 10, 2026 | 260.97M |
| Date | Value |
|---|---|
| September 09, 2026 | 274.43M |
| September 08, 2026 | 273.49M |
| September 04, 2026 | 273.74M |
| September 03, 2026 | 288.30M |
| September 02, 2026 | 287.07M |
| September 01, 2026 | 301.57M |
| August 31, 2026 | 325.11M |
| August 28, 2026 | 314.54M |
| August 27, 2026 | 313.44M |
| August 26, 2026 | 337.86M |
| August 25, 2026 | 321.84M |
| August 24, 2026 | 294.40M |
| August 21, 2026 | 285.17M |
| August 20, 2026 | 279.74M |
| August 19, 2026 | 271.59M |
| August 18, 2026 | 266.50M |
| August 17, 2026 | 268.33M |
| August 14, 2026 | 257.54M |
| August 13, 2026 | 267.44M |
| August 12, 2026 | 262.70M |
| August 11, 2026 | 254.62M |
| August 10, 2026 | 253.72M |
| August 07, 2026 | 253.26M |
| August 06, 2026 | 253.99M |
| August 05, 2026 | 253.94M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.388B |
| Alnylam Pharmaceuticals, Inc. | 31.11B |
| Anika Therapeutics, Inc. | 277.70M |
| Savara, Inc. | 977.70M |
| Vericel Corp. | 2.115B |
Market Cap Related Metrics
| PEG Ratio | -0.0315 |
| Price | 0.20 |
| Earnings Yield | -22.15% |
| PEGY Ratio | -0.0315 |